|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
2.30/3.08
|
企业价值
51.71B
|
资产负债 |
每股账面净值
11.81
|
现金流量 |
现金流量率
0.01
|
损益表 |
收益
6.00B
|
每股收益
9.66
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/14 16:33 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US. |